Bilaketaren emaitzak - Adam D. Pfefferle

  • Erakusten 1 - 13 emaitzak -- 13
Findu emaitzak
  1. 1
    Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression

    Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression nork Kevin Roarty, Adam D. Pfefferle, Chad J. Creighton, Charles M. Perou, Jeffrey M. Rosen

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential

    Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential nork Jelena Knežević, Adam D. Pfefferle, Ivana Petrović, Sandra B. Greene, Charles M. Perou, Jeffrey M. Rosen

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Oncogenic PI3K Mutations Lead to NF-κB–Dependent Cytokine Expression following Growth Factor Deprivation

    Oncogenic PI3K Mutations Lead to NF-κB–Dependent Cytokine Expression following Growth Factor Deprivation nork Jessica E. Hutti, Adam D. Pfefferle, Sean C. Russell, Mayukh Sircar, Charles M. Perou, Albert S. Baldwin

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Both Noncoding and Protein-Coding RNAs Contribute to Gene Expression Evolution in the Primate Brain

    Both Noncoding and Protein-Coding RNAs Contribute to Gene Expression Evolution in the Primate Brain nork Courtney C. Babbitt, Olivier Fédrigo, Adam D. Pfefferle, Alan P. Boyle, Julie E. Horvath, Terrence S. Furey, Gregory A. Wray

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis

    Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis nork J. Chuck Harrell, Adam D. Pfefferle, Nicole Zalles, Aleix Prat, Cheng Fan, Andrey Khramtsov, Olufunmilayo I. Olopade, Melissa A. Troester, Andrew C. Dudley, Charles M. Perou

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (<i>NF1</i>) as a Breast Cancer Driver

    Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (<i>NF1</i>) as a Breast Cancer Driver nork Marsha D. Wallace, Adam D. Pfefferle, Li Shen, Adrian J. McNairn, Ethan Cerami, Barbara L Fallon, Vera D. Rinaldi, Teresa Southard, Charles M. Perou, John C. Schimenti

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells

    Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells nork Patrick D. Rädler, Barbara L. Wehde, Aleata A. Triplett, Hridaya Shrestha, Jonathan H. Shepherd, Adam D. Pfefferle, Hallgeir Rui, Robert D. Cardiff, Charles M. Perou, Kay‐Uwe Wagner

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Mutant <i>PIK3CA</i> accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies

    Mutant <i>PIK3CA</i> accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies nork Ariella B. Hanker, Adam D. Pfefferle, Justin M. Balko, María G. Kuba, Christian D. Young, Violeta Sánchez, Cammie R. Sutton, Hailing Cheng, Charles M. Perou, Jean J. Zhao, Rebecca S. Cook, Carlos L. Arteaga

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts

    Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts nork Adam D. Pfefferle, Jason I. Herschkowitz, Jerry Usary, J. Chuck Harrell, Benjamin T. Spike, Jessica R. Adams, Maria I. Torres‐Arzayus, Myles Brown, Sean E. Egan, Geoffrey M. Wahl, Jeffrey M. Rosen, Charles M. Perou

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models

    Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models nork Patrick J. Roberts, Jerry Usary, David B. Darr, Patrick M. Dillon, Adam D. Pfefferle, Martin C. Whittle, James S. Duncan, Søren M. Johnson, Austin J. Combest, Jian Jin, William C. Zamboni, Gary L. Johnson, Charles M. Perou, Norman E. Sharpless

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma

    LKB1/STK11 Inactivation Leads to Expansion of a Prometastatic Tumor Subpopulation in Melanoma nork Wenjin Liu, Kimberly B. Monahan, Adam D. Pfefferle, Takeshi Shimamura, Jessica A. Sorrentino, Keefe T. Chan, David W. Roadcap, David W. Ollila, Nancy E. Thomas, Diego H. Castrillón, C. Ryan Miller, Charles M. Perou, Kwok‐Kin Wong, James E. Bear, Norman E. Sharpless

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study

    A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurren... nork Victoria Bae‐Jump, Michael W. Sill, Paola A. Gehrig, Jason D. Merker, David L. Corcoran, Adam D. Pfefferle, Michele C. Hayward, Joan L. Walker, Andrea R. Hagemann, Steven Waggoner, Roisin E. O’Cearbhaill, Megan McDonald, Mitchell I. Edelson, Paul DiSilvestro, Amy McNally, Aimee C. Fleury, Ramey D. Littell, Frederick R. Ueland, Heather A. Lankes, Carol Aghajanian

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer

    c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer nork Radhika Nair, Daniel Roden, Wee Siang Teo, Andrea McFarland, Simon Junankar, Shengzhi Ye, Akira Nguyen, Jean Yang, Iva Nikolić, Mun N. Hui, Adrienne Morey, Jaynish S. Shah, Adam D. Pfefferle, Jerry Usary, Christina Selinger, Laura A. Baker, Nicola J. Armstrong, Mark J. Cowley, Matthew J. Naylor, Christopher J. Ormandy, Sunil R. Lakhani, Jason I. Herschkowitz, Charles M. Perou, Warren Kaplan, Sandra O’Toole, Alexander Swarbrick

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: